John D Imig

Summary

Affiliation: Medical College of Georgia
Country: USA

Publications

  1. ncbi Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels
    John D Imig
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, USA
    Microcirculation 15:137-50. 2008
  2. ncbi Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors
    John D Imig
    Department of Physiology, Vascular Biology Center, Medical College of Georgia, Augusta, 30912, USA
    Cardiovasc Drug Rev 24:169-88. 2006
  3. ncbi Eicosanoids and renal damage in cardiometabolic syndrome
    John D Imig
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, USA
    Expert Opin Drug Metab Toxicol 4:165-74. 2008
  4. ncbi Eicosanoids and renal vascular function in diseases
    John D Imig
    Vascular Biology Center, Department of Physiology, Medical College of Georgia, Augusta, GA 30912, USA
    Clin Sci (Lond) 111:21-34. 2006
  5. ncbi Rofecoxib decreases renal injury in obese Zucker rats
    Aparajita Dey
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, USA
    Clin Sci (Lond) 107:561-70. 2004
  6. ncbi PPAR-alpha activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats
    Xueying Zhao
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912 2500
    Am J Physiol Heart Circ Physiol 290:H2187-95. 2006
  7. ncbi Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension
    Marlina Manhiani
    Vascular Biology Center, Medical College of Georgia, Augusta, Georgia, USA
    Am J Physiol Renal Physiol 297:F740-8. 2009
  8. ncbi Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats
    Ahmed A Elmarakby
    Department of Oral Biology Pharmacology, Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, U S A
    Clin Sci (Lond) 118:291-301. 2010
  9. ncbi Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats
    Jeffrey J Olearczyk
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, USA
    Clin Sci (Lond) 116:61-70. 2009
  10. ncbi Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension
    Xueying Zhao
    Vascular Biology Center, Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA 30912-3000, USA
    Hypertension 46:562-8. 2005

Research Grants

Collaborators

Detail Information

Publications60

  1. ncbi Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels
    John D Imig
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, USA
    Microcirculation 15:137-50. 2008
    ..These data support the concept that 11, 12-EET utilizes PP2A dependent pathways to activate large-conductance KCa channels and dilate the afferent arteriole...
  2. ncbi Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors
    John D Imig
    Department of Physiology, Vascular Biology Center, Medical College of Georgia, Augusta, 30912, USA
    Cardiovasc Drug Rev 24:169-88. 2006
    ..These findings of beneficial actions in animal models of disease position the sEH enzyme as a promising therapeutic target for cardiovascular diseases...
  3. ncbi Eicosanoids and renal damage in cardiometabolic syndrome
    John D Imig
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, USA
    Expert Opin Drug Metab Toxicol 4:165-74. 2008
    ..Although the number of patients with cardiometabolic syndrome is escalating, therapeutic approaches have not been developed that provide protection to the kidney...
  4. ncbi Eicosanoids and renal vascular function in diseases
    John D Imig
    Vascular Biology Center, Department of Physiology, Medical College of Georgia, Augusta, GA 30912, USA
    Clin Sci (Lond) 111:21-34. 2006
    ..This review highlights the roles of renal vascular eicosanoids in the pathogenesis of nephropathy and therapeutic targets for renal disease related to hypertension, diabetes, metabolic syndrome and acute renal failure...
  5. ncbi Rofecoxib decreases renal injury in obese Zucker rats
    Aparajita Dey
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, USA
    Clin Sci (Lond) 107:561-70. 2004
    ..These results suggest that altered vascular arachidonic acid enzymes contribute to the renal damage, and that COX-2 inhibition decreases glomerular injury in obese Zucker rats...
  6. ncbi PPAR-alpha activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats
    Xueying Zhao
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912 2500
    Am J Physiol Heart Circ Physiol 290:H2187-95. 2006
    ..These results demonstrate that the PPAR-alpha agonist fenofibrate increased renal CYP-derived eicosanoids and restored endothelial dilator function in obese Zucker rats...
  7. ncbi Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension
    Marlina Manhiani
    Vascular Biology Center, Medical College of Georgia, Augusta, Georgia, USA
    Am J Physiol Renal Physiol 297:F740-8. 2009
    ..These data demonstrate that Ephx2 gene deletion decreases blood pressure, attenuates renal inflammation, and ameliorates glomerular injury in DOCA-salt hypertension...
  8. ncbi Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats
    Ahmed A Elmarakby
    Department of Oral Biology Pharmacology, Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, U S A
    Clin Sci (Lond) 118:291-301. 2010
    ..These results suggest that ANG-induced hypertension exacerbates oxidative stress and renal inflammation without further impairment in vascular dysfunction in high-fat diet-induced obesity...
  9. ncbi Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats
    Jeffrey J Olearczyk
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, USA
    Clin Sci (Lond) 116:61-70. 2009
    ..Taken together, these results provide evidence that sEH inhibition with AUDA attenuates the progression of renal damage associated with hypertension and Type 2 diabetes...
  10. ncbi Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension
    Xueying Zhao
    Vascular Biology Center, Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA 30912-3000, USA
    Hypertension 46:562-8. 2005
    ..These results indicate that the impaired autoregulatory response observed in Ang II-dependent hypertension can be attributed to impairment of P2X1 receptor-mediated signal transduction...
  11. ncbi TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats
    Ahmed A Elmarakby
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912 2500, USA
    Am J Physiol Regul Integr Comp Physiol 294:R76-83. 2008
    ..These data support the hypothesis that TNF-alpha contributes to the increase in renal inflammation in DOCA-salt rats...
  12. ncbi Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes
    Ahmed A Elmarakby
    Georgia Health Sciences Univ, Augusta, GA, 30912
    Am J Physiol Regul Integr Comp Physiol 301:R1307-17. 2011
    ..These data demonstrate that Ephx2 KO improves endothelial function and reduces renal injury during diabetes. Additionally, our data also suggest that activation of HO-1 contributes to improved renal injury in diabetic Ephx2 KO mice...
  13. ncbi Novel nitric oxide synthase--dependent mechanism of vasorelaxation in small arteries from hypertensive rats
    Kyu Tae Kang
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, USA
    Hypertension 49:893-901. 2007
    ....
  14. ncbi Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension
    Sarah F Knight
    Vascular Biology Center, Medical College of Georgia, Augusta, Georgia, USA
    Am J Physiol Renal Physiol 298:F86-94. 2010
    ..These data indicate that tempol and simvastatin treatment via a reduction in oxidative stress improve renal endothelial function and decrease glomerular injury in a model of obesity and hypertension...
  15. ncbi Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats
    Xueying Zhao
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912-2500, USA
    Am J Physiol Regul Integr Comp Physiol 288:R188-96. 2005
    ....
  16. ncbi Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet
    Sarah F Knight
    Vascular Biology Center, Medical College of Georgia, Augusta, GA, USA
    Hypertension 51:352-9. 2008
    ....
  17. ncbi An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension
    John D Imig
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912 2500, USA
    Hypertension 46:975-81. 2005
    ..These data demonstrate that sEH inhibition lowers blood pressure and ameliorates renal damage in angiotensin-dependent, salt-sensitive hypertension...
  18. ncbi Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria
    Aparajita Dey
    Vascular Biology Center, Medical College of Georgia, 1120 Fifteenth Street, Augusta, GA 30912, USA
    Obes Res 12:1278-89. 2004
    ..To determine cytochrome P450 (CYP450) and cyclooxygenase (COX) expression and metabolite regulation and renal damage in the early stages of obesity-related hypertension and diabetes...
  19. ncbi Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension
    Ahmed A Elmarakby
    Vascular Biology Center, Medical College of Georgia, Augusta 30912 2500, USA
    Hypertension 50:1069-76. 2007
    ..These data suggest that CCR2b inhibition protects the kidney in hypertension by reducing inflammation and delaying the progression of hypertension...
  20. ncbi Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage
    Xueying Zhao
    Vascular Biology Center, Department of Physiology, Medical College of Georgia, Augusta, USA
    J Am Soc Nephrol 15:1244-53. 2004
    ..These data demonstrate that SEH inhibition has antihypertensive and renal vascular protective effects in angiotensin hypertension and suggests that SEH inhibitors may be a useful therapeutic intervention for cardiovascular diseases...
  21. ncbi Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension
    Jeffrey E Quigley
    Vascular Biology Center, Medical College of Georgia, Augusta, Georgia, USA
    Clin Exp Pharmacol Physiol 36:724-8. 2009
    ....
  22. ncbi Normalization of the ovarian cancer microenvironment by SPARC
    Neveen Said
    Vascular Biology Center, Medical College of Georgia, Augusta, Georgea 30912, USA
    Mol Cancer Res 5:1015-30. 2007
    ....
  23. ncbi Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases
    Xueying Zhao
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912-2500, USA
    Hypertension 42:775-80. 2003
    ..These results support the hypothesis that angiotensin II infusion induces persistent salt-sensitive hypertension after withdrawal of angiotensin II that may be due to downregulation of CYP2C and CYP2J epoxygenases in renal microvessels...
  24. ncbi An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats
    Anne M Dorrance
    Department of Physiology, Medical College of Georgia, Augusta, Georgia 30912, USA
    J Cardiovasc Pharmacol 46:842-8. 2005
    ..The results of this study provide novel evidence suggesting that the sEH inhibitor AUDA is a possible therapeutic agent for ischemic stroke...
  25. ncbi Protein phosphatase 2A and Ca2+-activated K+ channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation
    Christiana Dimitropoulou
    Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA, USA
    Prostaglandins Other Lipid Mediat 83:50-61. 2007
    ..These findings provide initial evidence that PP2A activity contributes to 11,12-EET and 11,12-EET analog activation of mesenteric resistant artery BK(Ca) channels and vasorelaxation...
  26. ncbi Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension
    Ahmed A Elmarakby
    Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, Georgia 30912, USA
    Vascul Pharmacol 46:144-51. 2007
    ..These data support the hypothesis that combined reduction of superoxide along with enhanced endogenous kinins may facilitate blood pressure lowering in Ang II hypertension...
  27. ncbi Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels
    Jeffrey J Olearczyk
    The Medical College of Georgia, Vascular Biology Center, Augusta, GA 30912, USA
    J Pharmacol Exp Ther 318:1307-14. 2006
    ....
  28. ncbi Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor
    Jia L Zhuo
    Department of Physiology, Tulane University School of Medicine, Veterans Administration Medical Center, New Orleans, Louisiana 70112, USA
    Hypertension 39:116-21. 2002
    ..These results indicate that there is substantial intracellular accumulation of angiotensin peptides in renal cortical endosomes during Ang II-dependent hypertension via an AT(1) receptor-mediated process...
  29. ncbi Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension
    Mong Heng Wang
    Department of Physiology, Medical College of Georgia, Augusta, GA 30912, USA
    Hypertension 42:594-9. 2003
    ..The reduction in the synthesis of these eicosanoids may play an important role in the regulation of renal function and blood pressure in obesity-induced hypertension...
  30. ncbi SPARC ameliorates ovarian cancer-associated inflammation
    Neveen A Said
    Vascular Biology Center, Medical College of Georgia, Augusta, GA, USA
    Neoplasia 10:1092-104. 2008
    ..These results indicate, for the first time, that the effects of tumor SPARC as a negative regulator of ovarian cancer are mediated through decreased recruitment of macrophages and downregulation of the associated inflammation...
  31. ncbi Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension
    Ahmed A Elmarakby
    Department of Physiology, Medical College of Georgia, Augusta, GA 30912 2500, USA
    Hypertension 47:557-62. 2006
    ..These data suggest that TNF-alpha contributes to downregulation of Cyp2c23, blood pressure regulation, and renal injury in angiotensin high-salt hypertension...
  32. ncbi Cytochrome P450 epoxygenases provide a novel mechanism for penile erection
    Liming Jin
    Department of Physiology, Medical College of Georgia, Augusta, Georgia, USA
    FASEB J 20:539-41. 2006
    ..Inhibition of this pathway attenuated erectile function, suggesting that EETs are required for normal erection...
  33. ncbi P2X receptor-stimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid
    Xueying Zhao
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912-2500, USA
    J Pharmacol Exp Ther 311:1211-7. 2004
    ..These results demonstrate that 20-HETE plays a significant role in the renal microvascular smooth muscle cell [Ca2+]i response to P2X receptor activation...
  34. ncbi L-type calcium channels in the renal microcirculatory response to endothelin
    David M Pollock
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912 2500, USA
    Am J Physiol Renal Physiol 288:F771-7. 2005
    ..These results support the hypothesis that L-type Ca(2+) channels play only a minor role in the constrictor responses to ET-1 in the renal microcirculation...
  35. ncbi ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin
    Edward W Inscho
    Department of Physiology, Medical College of Georgia, Augusta, GA 30912 3000, USA
    Br J Pharmacol 146:1019-26. 2005
    ....
  36. ncbi Elevated arterial pressure impairs autoregulation independently of AT(1) receptor activation
    Edward W Inscho
    Department of Physiology and Vascular Biology Center, Medical College of Georgia, Augusta, Georgia 30912, USA
    J Hypertens 22:811-8. 2004
    ..These studies determined the ability of AT1 receptor blockade or 'triple therapy', to reverse angiotensin II-induced hypertension and improve autoregulatory behavior...
  37. ncbi Peroxisome proliferator-activated receptor-alpha activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade
    Jan Michael Williams
    Department of Physiology, Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912 2500, USA
    Hypertension 46:366-71. 2005
    ..This suggests a possible relationship between ETB receptor activation and the maintenance of CYP4A protein expression in the kidney of rats fed a high-salt diet...
  38. ncbi Increased RhoA/Rho-kinase signaling mediates spontaneous tone in aorta from angiotensin II-induced hypertensive rats
    Liming Jin
    Department of Physiology, Medical College of Georgia, Augusta, GA, USA
    J Pharmacol Exp Ther 318:288-95. 2006
    ..Increased NADPH oxidase-dependent reactive oxygen species may be one of the mechanisms mediating the RhoA/Rho-kinase activation...
  39. ncbi Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension
    Xueying Zhao
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912-2500, USA
    Hypertension 41:709-14. 2003
    ....
  40. ncbi Angiotensin II hypertension is attenuated in interleukin-6 knockout mice
    Dexter L Lee
    Department of Physiology, Medical College of Georgia, Augusta, Georgia 30912 3000, USA
    Am J Physiol Heart Circ Physiol 290:H935-40. 2006
    ..In addition, the early separation in MAP, the albumin excretion data, and the rapid, post-ANG II recovery of MAP suggest an IL-6-dependent mechanism that is independent of renal injury...
  41. ncbi 12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels
    Shih Shen Yiu
    Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, USA
    J Lipid Res 44:2391-9. 2003
    ....
  42. ncbi Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior
    Edward W Inscho
    Department of Physiology, Medical College of Georgia, 1120 15th Street, Augusta, Georgia 30912 3000, USA
    J Clin Invest 112:1895-905. 2003
    ..These data provide compelling new evidence indicating that tubuloglomerular feedback signals are coupled to autoregulatory preglomerular vasoconstriction through ATP-mediated activation of P2X1 receptors...
  43. ncbi Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension
    Matthew J Socha
    Vascular Biology Center, Medical College of Georgia, 1459 Laney Walker Blvd, CB 3306, Augusta, GA 30912, USA
    Am J Pathol 171:1104-12. 2007
    ..These results identify SPARC as an effector of ANG II signaling and suggest an important role for SPARC in mediating ANG II-induced oxidative stress, inflammation, and fibrosis...
  44. ncbi Renal AT1 receptor protein expression during the early stage of diabetes mellitus
    Lisa M Harrison-Bernard
    Department of Physiology, Tulane University School of Medicine, New Orleans, LA, USA
    Int J Exp Diabetes Res 3:97-108. 2002
    ..Increased renal cortical AT1 receptor protein and circulating AngII levels are consistent with an exaggerated AngII-dependent influence on renal function during the early stage of DM in the rat...
  45. ncbi Contribution of prostaglandin EP(2) receptors to renal microvascular reactivity in mice
    John D Imig
    Vascular Biology Center, Department of Physiology, Medical College of Georgia, Augusta, Georgia 30912, USA
    Am J Physiol Renal Physiol 283:F415-22. 2002
    ..These results demonstrate that the EP(2) receptor mediates a portion of the PGE(2) afferent arteriolar vasodilation and buffers the renal vasoconstrictor responses elicited by EP(1) and EP(3) receptor activation as well as endothelin-1...
  46. ncbi The Bradykinin B2 receptor is required for full expression of renal COX-2 and renin
    John D Imig
    Department of Physiology, Medical College of Georgia, Vascular Biology Center, Augusta, GA 30912 2500, USA
    Peptides 24:1141-7. 2003
    ..The results of these studies demonstrate suppression of renal renin synthesis in mice lacking the bradykinin B2R and support the notion that B2R regulation of COX-2 participates in the steady-state control of renin gene expression...
  47. ncbi Obesity, insulin resistance, and renal function
    Sarah F Knight
    Vascular Biology Center, Medical College of Georgia, Augusta, Georgia 30912, USA
    Microcirculation 14:349-62. 2007
    ....
  48. ncbi Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases
    John D Imig
    Vascular Biology Ctr, Medical College of Georgia, Augusta, GA 30912 2500, USA
    Am J Physiol Renal Physiol 289:F496-503. 2005
    ..Thus the renal and cardiovascular protective actions of increasing epoxygenase levels could be translated to therapies for preventing end-organ damage...
  49. ncbi Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension
    John D Imig
    Vascular Biology Center, Department of Physiology, Medical College of Georgia, Augusta, GA 30912 2500, USA
    Hypertension 39:690-4. 2002
    ..Moreover, sEH plays a role in the regulation of blood pressure, and inhibition of sEH during Ang II hypertension is antihypertensive...
  50. ncbi Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy
    Xueying Zhao
    Department of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA
    Am J Nephrol 34:268-80. 2011
    ..Studies have shown that kidney injury molecule-1 (KIM-1) is upregulated in damaged renal proximal tubules. In this study, we examined KIM-1 expression in glomerular epithelial cells in diabetic glomerulopathy...
  51. ncbi Age-related alterations in NOS and oxidative stress in mesenteric arteries from male and female rats
    Jennifer C Sullivan
    Medical College of Georgia, Vascular Biology Center, 1459 Laney Walker Blvd, Augusta, GA 30912, USA
    J Appl Physiol 97:1268-74. 2004
    ..These data suggest that age-related alterations in the resistance vasculature are complex and likely involve multiple compensating vasoactive pathways...
  52. ncbi Adaptations of the renal microcirculation to hypertension
    John D Imig
    Department of Physiology, Medical College of Georgia, Augusta, GA 30912 2500, USA
    Microcirculation 9:315-28. 2002
    ....
  53. ncbi ACE Inhibition and Bradykinin-Mediated Renal Vascular Responses: EDHF Involvement
    John D Imig
    Hypertension 43:533-5. 2004
  54. ncbi Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes
    Vera Portik-Dobos
    Program in Clinical and Experimental Therapeutics, Univerisity of Georgia, College of Pharmacy, Georgia 3091, USA
    Am J Physiol Regul Integr Comp Physiol 290:R435-41. 2006
    ..Although the ET(A) receptor subtype is not involved in the early activation of MMPs in type 2 diabetes, ET-1 contributes to transactivation of growth-promoting and profibrotic EGFR...
  55. ncbi 20-HETE or EETs: which arachidonic acid metabolite regulates proximal tubule transporters and contributes to pressure natriuresis?
    John D Imig
    Am J Physiol Regul Integr Comp Physiol 287:R3-5. 2004
  56. ncbi The roles of intrarenal 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of renal function in hypertensive Ren-2 transgenic rats
    Vera Certíková Chábová
    Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
    Kidney Blood Press Res 30:335-46. 2007
    ..Second, the renal functional responses to inhibition of the intrarenal formation of 20-HETE and EETs were investigated...
  57. ncbi Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting
    Youfei Guan
    Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    J Clin Invest 117:2496-505. 2007
    ..Similarly, the pressor response to EP1-selective agonists sulprostone and 17-phenyltrinor PGE2 were blunted by SC51322 and in EP1-null mice. These data support the possibility of targeting the EP1 receptor for antihypertensive therapy...
  58. ncbi Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats
    Věra Čertíková Chábová
    Department of Nephrology, 1st Medical Faculty, Charles University, Prague, Czech Republic
    Vascul Pharmacol 47:145-59. 2007
    ..Our data suggest that altered production and/or action of CYP-derived metabolites play a permissive role in the development and maintenance of hypertension in TGR by enhancing ANG II-induced vasoconstriction...
  59. ncbi Calcium and chloride channel activation by angiotensin II-AT1 receptors in preglomerular vascular smooth muscle cells
    Andrew J Fuller
    Dept. of Physiology SL#39, Tulane Univ. School of Medicine, 1430 Tulane Ave, New Orleans, LA 70112, USA
    Am J Physiol Renal Physiol 289:F760-7. 2005
    ..The finding that chloride channel blockers markedly attenuate both rapid and sustained responses indicates that chloride channel activation contributes to, rather than being the consequence of, the initial rapid response...
  60. ncbi Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors
    Jian Kang Chen
    Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA
    J Biol Chem 283:24514-24. 2008
    ....

Research Grants1

  1. Novel epoxide hydrolase inhibitor for stroke prevention
    JOHN IMIG; Fiscal Year: 2005
    ..In the Phase II work, Arete Therapeutics will use the collected information to progress toward clinical trials in the area of stroke and possible new therapeutic avenues. ..